(구)글로벌 핫이슈
방사선종양학
- 2017년 01월호[Clin Cancer Res.] Focal Adhesion Kinase Regulates the DNA Damage Response and Its Inhibition Radiosensitizes Mutant KRAS Lung Cancer.
University of Texas Southwestern Medical Center / Pier Paolo Scaglioni* 2016 Dec 1댓글: 0조회수: 1268
- 2017년 01월호[J Clin Oncol.] Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update.
American Society of Clinical Oncology / Mark R. Somerfield*2016 Dec 20댓글: 1조회수: 1295
- 2017년 01월호[Lancet Oncol.] Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.
The University of Texas MD Anderson Cancer Center / Daniel R Gomez*2016 Dec댓글: 0조회수: 1414
- 2016년 12월호[Clin Cancer Res.] Rectal Cancer: Assessment of Neoadjuvant Chemoradiation Outcome based on Radiomics of Multiparametric MRI.
Zhejiang University School of Medicine / Xiaonan Sun* 2016 Nov 1댓글: 0조회수: 1358
- 2016년 12월호[Clin Cancer Res.] Ultrastructural Insights into the Biological Significance of Persisting DNA Damage Foci after Low Doses of Ionizing Radiation.
Saarland University / Claudia E. Rube* 2016 Nov 1댓글: 0조회수: 1361
- 2016년 12월호[J Clin Oncol.] Improved Metastasis-Free and Survival Outcomes With Early Salvage Radiotherapy in Men With Detectable Prostate-Specific Antigen After Prostatectomy for Prostate Cancer.
Mayo Clinic / Thomas M. Pisansky* 2016 Aug 1댓글: 0조회수: 1298
- 2016년 12월호[J Clin Oncol.] Effect of Interval (7 or 11 weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR-6).
Hopital Saint Antoine / Jérémie H. Lefevre*2016 Jul 18. 댓글: 0조회수: 1280
- 2016년 12월호[Lancet Oncol.] Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial.
Collaborative Innovation Centre of Cancer Medicine / Jun Ma*2016 Nov댓글: 0조회수: 1359
- 2016년 12월호[Lancet Oncol.] Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.
European Organisation for Research and Treatment of Cancer / Brigitta G Baumert*2016 Nov댓글: 1조회수: 1396
- 2016년 12월호[Lancet Oncol.] Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.
VU University Medical Centre / Jaap C Reijneveld*2016 Nov댓글: 0조회수: 1303
